Evidence map›Paper›PMID 42902994›Full record

ArticleInternational journal of MS care2025

Long-Term Changes in Patient-Reported Outcome Measures in People With Multiple Sclerosis 55 Years and Older: Analysis From the New York State Multiple Sclerosis Consortium.

Dejan Jakimovski, Katelyn S Kavak, Patricia K Coyle, Andrew D Goodman, Malcolm H Gottesman, Bianca Weinstock-Guttman, New York State Multiple Sclerosis Consortium

Abstract read
In one paragraph

Article in International journal of MS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dejan JakimovskiBuffalo Neuroimaging Analysis Center and Jacobs Multiple Sclerosis Center for Treatment and Research, University at Buffalo, State University of New York, Buffalo, NY.ORCID https://orcid.org/0000-0001-7114-4958
Katelyn S KavakBuffalo Neuroimaging Analysis Center and Jacobs Multiple Sclerosis Center for Treatment and Research, University at Buffalo, State University of New York, Buffalo, NY.
Patricia K CoyleBuffalo Neuroimaging Analysis Center and Jacobs Multiple Sclerosis Center for Treatment and Research, University at Buffalo, State University of New York, Buffalo, NY.
Andrew D GoodmanBuffalo Neuroimaging Analysis Center and Jacobs Multiple Sclerosis Center for Treatment and Research, University at Buffalo, State University of New York, Buffalo, NY.
Malcolm H GottesmanNYU Langone Ambulatory Care, East Meadow, East Meadow, NY.
Bianca Weinstock-GuttmanDepartment of Neurology (BW-G), University at Buffalo, Buffalo, NY, USA.ORCID https://orcid.org/0000-0002-7648-027X
New York State Multiple Sclerosis ConsortiumBuffalo Neuroimaging Analysis Center and Jacobs Multiple Sclerosis Center for Treatment and Research, University at Buffalo, State University of New York, Buffalo, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient-reported outcome measures (PROMs) are increasingly utilized in observational and regulated studies of people with multiple sclerosis (MS). However, the impact of aging on PROMs for people with MS remains largely unknown. This study explores the cross-sectional characteristics and longitudinal trajectories of PROMs to determine their ability to predict clinical progression in a large group of people with MS 55 years and older. Methods: Included in the analysis were people with MS enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC), 55 years or older, with at least 3 clinical visits recorded in the consortium database. All people in the NYSMSC complete PROMs through the LIFEware questionnaire. Additional clinical measures were also collected. The percentage of people with MS who reported severe limitations within each of the LIFEware domains was compared at their baseline visit (≥ 55 years) and at the most recent follow-up visit (average follow-up of 8.3 years). Comparisons between people with MS with stable or increasing disability were also performed. Results: Of 658 eligible people in the NYSMSC (mean age at most recent follow-up, 66.6 years), a greater percentage reported decreased ability since baseline in all physical PROMs domains (getting up from sofa, 38.4% to 48.8%, Conclusions: An increase in physical limitations does not necessarily contribute to a rise in psychosocial limitations. Instead, as people with MS age, they tend to report improvements in their mental health over time. PROMs can be a complementary predictive indicator of future disease progression as individuals with MS age.

Indexed as

aginglong-term outcomespatient-reported outcome measuresphysical disabilityPROMspsychosocial

Identifiers

PMID42902994
PMCPMC13629423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.